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Zusammenfassung
Hintergrund: In einer Pilotstudie mit Patienten, die an chro-
nischen Rückenschmerzen leiden, wurde ein 8-wöchiges 
Achtsamkeitsprogramm auf dessen Durchführbarkeit und 
Wirksamkeit untersucht. Berücksichtigt wurden dabei auch 
im EEG nachweisbare Veränderungen, die auf thalamokorti-
kale Dysrhythmie schließen lassen, eine neuronale Störung, 
die mit chronischen Schmerzen in Beziehung steht. Patien-
ten und Methoden: 22 Patienten mit chronischen Rücken-
schmerzen nahmen an einem Kurs in achtsamkeitsbasierter 
Stressbewältigung (MBSR) teil. Abhängige Variablen waren 
selbstberichtete Maße zu Psychopathologie, Schmerz und 
Lebensqualität sowie 4 Parameter aus dem Powerspektrum 
des EEG. Ergebnisse: Mittelgroße Effektstärken wurden für 
die Variablen Lebensqualität (EQ-5D, VAS, d = 0,43, p = 0,02; 
SF-12, Psychische Summenskala, d = 0,50, p = 0,05), ge-
sundheitsbezogene Lebenszufriedenheit (Fragebogen zur 
Lebenszufriedenheit, d = 0,69, p = 0,01), Depressivität (HADS, 
d = 0,48, p = 0,04, Brief Symptom Inventory d = 0,41, p = 
0,04) und affektives Schmerzempfinden (Schmerzempfin-
dungsskala d = 0,50, p = 0,04) gefunden. Die bedeutsamsten 
Schmerzmaße (VAS) besserten sich im Bereich von d = 
0,45–0,75 (p = 0,01-0,24). Im EEG konnten keine Unter-
schiede gefunden werden. Schlussfolgerung: MBSR ist eine 
praktikable Intervention bei chronischen Rückenschmerzen. 
Die Patienten profitieren von den mittleren Effektstärken, 
die mit denen ähnlicher, verhaltenstherapeutischer Inter-
ventionen vergleichbar sind. Zur Untersuchung der Spezi-
fizität der Wirkung müssen randomisierte kontrollierte 
 Studien durchgeführt werden.
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Summary
Background: A pilot study of an 8-week mindfulness-based 
stress reduction (MBSR) program on a sample of low back 
pain patients was conducted in order to assess the feasibil-
ity and effectiveness of the intervention as well as changes 
in an EEG pattern called thalamocortical dysrhythmia which 
is associated with chronic pain. Patients and Methods: 22 
patients with chronic low back pain participated in an MBSR 
program. Effect sizes were measured for psychological 
functioning, pain severity, and quality of life. Furthermore, 
4 parameters of the EEG power spectral density were as-
sessed. Results: Medium size effect sizes were found for 
health-related quality of life (EQ-5D, VAS, d = 0.43, p = 0.02; 
SF-12, psychological functioning, d = 0.50, p = 0.05), health-
related life satisfaction (questions on life satisfaction d = 
0.69, p = 0.01), depression (HADS, d = 0.48, p = 0.04, Brief 
Symptom Inventory d = 0.41, p = 0.04), and affective pain 
perception (pain perception scale d = 0.50, p = 0.04). The 
most relevant pain severity measurements improved in the 
range of d = 0.45–0.75 (p = 0.01–0.24). EEG analyses re-
vealed no differences between the pre- and post-interven-
tion. Conclusion: MBSR is a feasible intervention for pa-
tients with low back pain. They benefit from medium size 
effects which are comparable to similar behavioral interven-
tions. Randomized controlled trials are needed in order to 
determine the specificity of these benefits. 
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Introduction 
Mindfulness-based interventions have proved to be moderately 
effective in the treatment of chronic pain and the accompanying 
distress and psychological morbidity [1]. Low back pain (LBP) is 
the most prevalent chronic pain condition, with a major impact on 
public health and witch accompanying economic consequences [2, 
3]. Some of the best treatment options for LBP are multidiscipli-
nary pain management programs [4, 5], many of which also con-
tain mindfulness-based or acceptance-based elements. However, 
evidence for the effectiveness of mindfulness-based interventions is 
scarce. A recent review [6] identified only 3 randomized controlled 
trials (RCTs), 2 of which involved a population >65 years [7, 8] of 
age; 1 assessed a population with failed back pain surgery [9]. Fur-
thermore, there is an observational trial piloting an intervention 
which combines mindfulness-based and physiotherapeutic ele-
ments [10]. 
The most widespread meditation-based intervention is the 
structured 8-week course Mindfulness-based Stress Reduction 
(MBSR) by Jon Kabat-Zinn [11]. This program was applied in 
many chronic pain conditions [12], such as fibromyalgia [13, 14] 
and rheumatoid arthritis [15]. 
The effects of MBSR are highest with respect to stress and psy-
chological problems, such as depression and anxiety [16, 17]. In 
this program, the patients learn, among other things, a different 
approach to their illness with respect to self-regulation capacities 
for pain and negative emotions in order to improve the experience 
of control. It is assumed that such a change of attitude towards 
ones illness can in turn also influence pain perception and may also 
break up psychological chronification patterns. 
To date, little is known about the accompanying neural mecha-
nisms of chronic pain, [18]. Recent studies have identified a rela-
tionship between severe neurogenic pain and the presence of a spe-
cific EEG pattern called thalamocortical dysrhythmia (TCD) [19–
22]. Sarnthein et al. [23] compared the EEG spectrum of 15 pa-
tients with severe chronic pain with matched healthy controls, and 
found marked differences both with respect to the power in the 
theta and beta domains and in the frequency of the peak of the 
power spectral density. We replicated this study with a more gen-
eral sample of LBP patients by comparing their EEG patterns to 
matched healthy controls [24] but found no differences in TCD 
patterns. This was most likely due to the fact that LBP patients have 
pain of nociceptive and psychogenic origin rather than of neuro-
genic source. Nevertheless, we are interested whether a longitudi-
nal design with intervention changes and subjective pain reports 
will result in changes in TCD-related patterns. 
Since to date no simple trial has been carried out assessing the 
effects of an MBSR program with a self-selected LBP population, 
we conducted a pilot study with the following objectives: (1) assess-
ing changes of EEG patterns in relation to changes of pain experi-
ence after a behavioral intervention; (2) estimating effect sizes with 
respect to psychological morbidity and coping aspects in LBP; and 




We conducted an observational pilot trial. Measurements were taken at en-
rolment (t0, EEG and questionnaire), directly before (t1, questionnaire), and 
after the intervention (t2, EEG and questionnaire). The total recruitment period 
was 6 months. The 8-week MBSR course started 4 months after the end of the 
recruitment. At t0, results of the EEG assessment of the TCD pattern were com-
pared to a healthy gender- and age-matched control. This part of the study has 
previously been published [24] and will not be reported here. The study was 
approved by the ethics committee of the Medical Center – University of 
Freiburg and registered before the start of recruitment with clinicaltrials.gov 
(NCT00744575).
Participants
For the EEG diagnostic study [24] and an optional MBSR intervention, the 
participants were recruited via public announcements and via pain specialists. 
The applicants were screened on the phone followed by an intake interview 
which was conducted by a medical doctor. 
Inclusion criteria were chronic back pain for at least 1 year, daily complaints 
about back pain, an average pain rating of at least 5 for the last 12 months on a 
Visual Analog Scale (VAS) ranging from 0 to 10, age from 18 to 70 years, and 
command of the German language. Exclusion criteria were the presence of psy-
chiatric conditions, including substance dependence, immunosuppressive treat-
ment, life-threatening disease, and participation in other clinical trials. Patients 
were informed of all aspects of the study and gave written informed consent. 
Intervention 
The MBSR intervention was closely based upon the original program by Jon 
Kabat-Zinn [25]. It comprised an 8-week structured group program, with 
groups of up to 12 patients. Participants took part in one 2.5-h session every 
week, one additional all-day session, and an individual pre- and post-interven-
tion interview with the trainer. Each session covered specific exercises and topics 
within the context of mindfulness practice and training, including various types 
of formal mindfulness practice, mindful awareness of dynamic yoga postures, 
and mindfulness during stressful situations and social interactions. Participants 
were asked to commit themselves to daily homework assignments of 45–60 min. 
The MBSR instructors were 2 male medical doctors (MDs) with expertise in psy-
chosomatic and psychiatric medicine who had conducted MBSR training pro-
grams in the past and are approved by the German MBSR/MBCT association. 
Measures
EuroQol Quality of Life Questionnaire (EQ-5D) [26]: This is a simple 5-item 
questionnaire for health-related quality of life (HRQoL). It includes a VAS re-
garding general state of health.
Twelve-Item Short Form Health Survey (SF-12) [27]: The SF-12 is a 12-item 
scale for the assessment of HRQoL. 2 subscales are constructed from the data 
(psychological and physiological functioning) which can be compared to the 
population values. 
Brief Symptom Inventory (BSI) [28, 29]: This is the 53-item symptom check 
list functioning as screening instrument to assess psychopathology. The BSI al-
lows for the calculation of 9 subscales and a Global Severity Index (GSI) reflect-
ing overall burden.
Hospital Anxiety and Depression Scale (HADS) [30]: This is a short 14-item 
screening instrument for anxiety and depression disorder which has 2 
subscales.
Pain Perception Scale (PPS) [31]: A German questionnaire measuring sub-
jective pain perception on 2 subscales: sensory (10 items) and affective pain (14 
items).
Visual Analogue Scales (VAS) assessing pain severity: VAS comprised the an-
chor points ‘no pain at all’ and ‘worst pain possible’. We assessed average pain 
in the previous 4 weeks, 3 months, and 12 months respectively. We also asked 
for the ‘strongest’ and ‘lowest pain intensity within the previous 4 weeks’. Fur-
thermore, we assessed changes in pain severity by retrospective one-point 















































to the enrolment (at t1) or referring to enrolment and to the start of the course 
(at t2). These questions had a 7-step numeric rating scale ranging from –3 
(worse) to 0 (unchanged) to +3 (better).
Questions on Life Satisfaction (FLZ) [32]: This is a 32-item German ques-
tionnaire assessing generic as well as health-related life satisfaction in 8 differ-
ent dimensions. Each dimension needs to be weighted regarding both individ-
ual importance and individual satisfaction. Based on this information, an indi-
vidually weighted sum score for generic and health-related life satisfaction re-
spectively was computed. 
EEG
EEG was recorded in a sound- and electromagnetically-shielded, dimly lit 
chamber, with a 72-channel amplifier (Quickamp, Brain Products, Munich, 
 Germany, bandpass filtered 0–200 Hz; A/D rate1000 Hz) according to the inter-
national 10/10 system, from 60 electrode sites plus diagonal EOG. We used an 
ActiCap System (Brain Products, Munich, Germany) that includes a cap with 
 active electrodes. Electrode impedances were kept under 5 kΩ. All measurements 
were performed before noon in order to avoid sleepiness. Patients were required 
to abstain from caffeine on the day of measurement since caffeine is known to 
 influence theta activity [33]. 
Statistics and Data Analysis
EEG Data
All data analyses were performed with Brain Vision Analyser 2.0 (Brain 
Products, Munich, Germany) and custom scripts in MatLab (MathWorks, 
Natick, MA, USA). After artefact inspection and elimination data were band-
pass-filtered (1–30 Hz) and segmented into 4-s epochs (with 2 s overlapping). 
For each patient, 100 free-of-artefact segments were included in further analy-
ses. A discrete 4000-sample Fast Fourier Transformation (FFT) was computed 
for each segment. The topographic distribution of power spectral density (PSD) 
was obtained by averaging across all 100 epochs. We then averaged the log-
transformed spectra across all channels for each participant. 
From this PSD the frequency of the dominant peak (peak frequency) and the 
log-transformed PSD values at this frequency (peak power) was determined. For 
each patient a region of interest (ROI) was defined by ± 2 standard deviations (SD) 
of the mean peak frequency. Within this ROI the overall power and its center of 
gravity was computed. By this procedure we arrived at 4 different variables (peak 
frequency, peak power, center of gravity, and overall power) for subsequent analy-
ses. For a more detailed account of the EEG data processing see Schmidt et al. [24].
Questionnaire data were entered into SPSS software (Version 17 and 19) by 
hand. The questionnaires of a randomly selected subsample of 10 patients were 
entered a second time by a different person to control for coding errors. Miss-
ing items were replaced according to the respective questionnaire manual (re-
placement by means). In the analysis, we only included patients who had com-
pleted the intervention per protocol which was defined as attending at least 6 of 
the 8 sessions. 
Intervention effects were assessed by t-tests for dependent data if variables 
were normally distributed; in all other cases Wilcoxon signed-rank tests were 
used. We calculated pre-post effect sizes (Cohen’s d) by computing the differ-
ence of the respective means divided by their pooled SD. 
Results
Patients
Overall 62 patients with LBP were screened on the phone, 38 of 
which participated in the preceding EEG diagnostic study [24]. 22 
of them volunteered to participate in the MBSR intervention. One 
participant visited only one session and then dropped out. The re-
maining 21 participants (95%) completed the study per protocol 
and were subject to the further analyses (table 1).
Psychological Health
Table  2 displays the data of the 6 self-report scales applied to 
measure psychological health. 
Patients showed a significant improvement both in HRQoL 
(d = 0.43, p = 0.02) and on the psychological dimension of the SF-12 
(d = 0.50, p = 0.05) with a medium effect size. There was scant change 
on the physiological dimension of the SF-12. Regarding general life 
satisfaction, patients showed a small increase  (d = 0.29) but medium 
to large increase in health-related life satisfaction (d = 0.69, p = 0.01).
Regarding psychological morbidity, patients showed only small 
non-significant improvements in 7 of 9 scales of the BSI, including 
GSI. The only exception was the subscale depression, with a signifi-
cant medium-sized improvement of d = 0.41 (p = 0.04). This find-
ing is supported by a similar improvement on the depression sub-
scale of HADS (d = 0.48; p = 0.01), while there is a non-significant 
improvement of d = 0.33 on the anxiety subscale. Finally, there is a 
significant medium-sized improvement on the affective dimension 
of the pain perception scale (d = 0.50, p = 0.04), but not in the sen-
sory dimension.
Pain 
Subjective pain was measured with VAS at 3 time points 
(table 3): upon enrolment (t0), immediately before the start of the 
course (t1, 6–10 months later), and immediately after the course 
(t2, 8 weeks after t1).
The average pain during the previous 4 weeks showed an im-
provement at t2, with a medium effect size of 0.48 (p = 0.056) com-
pared to enrolment (t0) and of 0.46 (p = 0.03) compared to t1, im-
mediately before the start of the course. The improvement was 
similar for the average pain score of the previous 3 months, with d 
= 0.46 compared to t1, but differed regarding t0 with a smaller 
 effect size of d = 0.21. Of note, for the variable ‘average pain in the 
previous 12 months’, patients reported an increase in severity by 
d = –0.44 compared to t0, in contradiction to all other pain meas-
urements. The maximum and minimum pain showed an improve-
ment of d = 1.15 and d = 0.64 respectively (all highly significant). 
The additional retrospective one-point measurement at t1 refer-
ring to enrolment revealed a mean change of d = –0.15 indicating 
Table 1. Sociodemographic data of the sample
N = 21
Age (SD) 47.8 (10.27)
Sex (m/f) (5/16)
Education level (%)
9 years  2 (9.5)
11 years/GCSE 10 (47.6)
A-level/college entry level  9 (42.9)
Marital status
Married, living together  9 (42.9)
Widowed  1 (4.8)
Divorced  3 (14.3)
Single  8 (38.1)
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that there was no change in pain between study enrolment and 
start of the intervention. At t2 patients reported an improvement of 
1.08 (SD = 1.08, t = 4.25, df = 18, p < 0.001, d = 1.00) on the applied 
7-point scale, as compared to t0 (enrolment), and of 1.11 (SD 1.20, 
t = 4.03, df = 19, p = 0.001, d = 0.92) as compared to t1.
With respect to the minimum clinical important difference 
(MCID) a change of at least 2.5 points on a numeric rating scale for 
pain should be found [34]. For the average pain in the last 4 weeks, 
this level was reached in the present study by 6 out of 21 patients 
(29%), 10 patients (48%) reported a change of 2 points. 
t0 t2     T df p     d
HRQoL, n = 21
EQ-5D VAS scale 55.81 (20.22) 64.57 (19.92)     2.54 20 0.019     0.43
SF-12, n = 19
Physiological functioning 33.73 (9.87) 35.47 (9.61)     1.04 18 0.31     0.18
Psychological functioning 41.08 (12.31) 47.25 (10.58)     2.12 18 0.048     0.50
BSI 
GSI, n = 21  0.80 (0.56)  0.72 (0.47)     0.82 20 0.42     0.14
Somatization, n = 20  0.91 (0.66)  1.02 (0.59) –1.19 19 0.25 –0.17
Obsessive-compulsive disorder, n = 21  1.19 (0.75)  1.06 (0.79)     0.74 20 0.47     0.17
Depression, n = 21  0.83 (0.76)  0.52 (0.50)     2.26 20 0.035     0.41
Anxiety, n = 21  0.85 (0.68)  0.80 (0.66)     0.47 20 0.64     0.07
Phobic anxiety, n = 21*  0.70 (0.93)  0.56 (0.62) –0.51** – 0.61     0.15
Interpersonal sensitivity, n = 21  0.88 (0.93)  0.76 (0.68)     0.73 20 0.475     0.13
Hostility, n = 21  0.62 (0.56)  0.69 (0.61) –0.48 20 0.64 –0.13
Paranoid ideation, n = 21*  0.72 (0.72)  0.57 (0.64) –1.37** – 0.17     0.21
Psychoticism, n = 21  0.44 (0.55)  0.36 (0.36)     0.59 20 0.56     0.15
FLZ 
General life satisfaction, n = 21 27.36 (35.57) 37.71 (39.82)     2.10 20 0.049     0.29
Health-related life satisfaction, n = 21 22.51 (27.47) 41.33 (39.76)     3.04 20 0.007     0.69
HADS
Anxiety, n = 21  8.71 (3.65)  7.52 (4.11) –1.37 20 0.19     0.33
Depression, n = 21  7.75 (4.45)  5.62 (3.06) –2.86 20 0.010     0.48
PPS
Affective, n = 20 32.6 (9.56) 27.79 (8.33) –2.24 19 0.038     0.50
Sensory, n = 21 18.59 (5.75) 17.33 (5.49) –0.87 20 0.40     0.22
HRQoL = questionnaire for health-related quality of life ; EQ-5D = EuroQol Quality of Life Questionnaire; SF-12 = 12-Item Short 
Form Health Survey; BSI = Brief Symptom Inventory; GSI = Global Severity Index; FLZ = Questions on Life Satisfaction; HADS = 
Hospital Anxiety and Depression Scale; PPS = Pain Perception Scale; 
*Wilcoxon test.
**Z-score.
Table 2. Means, 
standard deviations 
(SD), test parameters, 
p-values, and effect size 
(Cohen’s d) for health-
related parameters. 
Positive effect sizes 
 indicate improvement
t0 t1 t2 t0–t2 t1–t2
mean (SD) mean (SD) mean (SD) n p     d n p     d
Pain VAS
Average 4 weeks 5.86 (2.15) 5.40 (1.54) 4.55 (2.09) 21 0.056     0.48 20 0.034     0.46
Average 3 months 5.25 (1.45) 5.63 (1.42) 5.00 (1.41) 20 0.437     0.21 19 0.08     0.45
Average 12 months 5.55 (1.74) 6.17 (1.62) 6.39 (1.34) 19 0.039 –0.44 18 0.50 –0.15
Maximum 4 weeks 8.19 (1.32) 7.91 (1.66) 6.67 (1.77) 21 0.003     1.15 21 0.24     0.75
Minimum 4 weeks 3.12 (1.52) 3.10 (1.64) 2.14 (1.49) 21 0.002     0.64 21 0.009     0.59
Table 3. Pain ratings 
on a Visual Analog 
Scale (VAS) at t0 
 (enrolment), t1 (before 
 intervention), and t2 
(after intervention). 
Positive effect sizes 
 indicate improvement
t0 t2    t df p d
Peak freqency, Hz   10.35 (1.27)    9.90 (1.21)     1.20 20 0.24 0.35
Peak power, μV²/Hz* 1834.75 (2852.91) 1901.14 (2271.50) –0.24 20 0.81 0.02
Center of gravity, Hz   10.06 (0.48)    9.89 (0.46)     2.19 20 0.040 0.35
Overall power, μV²/Hz* 8304.49 (11302.26) 9883.72 (11082.18) –1.48 20 0.15 0.14
*Log-transformed.
Table 4. Means, 
standard deviations 
(SD), test parameters, 
p-values, and effect size 



















































According to the theory of TCD, an improvement in pain 
should correlate with a shift of the peak frequency and center of 
gravity towards a higher frequency and a general lower overall 
power and peak power. Table 4 shows that all 4 parameters shift 
opposite to the estimated direction, none of which is statistically 
significant. 
We also correlated change in average pain perception during 
the last 4 weeks with changes in TCD-related EEG variables be-
tween the 2 measurements (t0 and t2). Here, all correlations headed 
towards the intended direction, with pain improvement resulting 
in lower overall power (Spearman’s r = 0.54, p = 0.01) and lower 
peak power (r = 0.19, n.s.) on the one hand and an increase in peak 
frequency (r = –0.41, p = 0.06) and center of gravity (r = 0.35, n.s.) 
on the other. However, if these results are corrected for multiple 
analyses no significant correlations remain.
Discussion
The results of our pilot trial demonstrate that MBSR is a feasible 
intervention for LBP patients. Of 22 patients, 21 completed the 
course per protocol, with only one dropout due to time constraints. 
The patients reported improvements with medium to large effect 
size for health-related life satisfaction and medium size effect sizes 
for HRQoL, psychological functioning, depression, and for affec-
tive pain perception. 
Furthermore patients stated a medium-size improvement in 
pain severity, with effect sizes of d = 0.45 for average pain ratings 
after the intervention. These effect sizes were slightly higher for 
maximum and minimum pain ratings (d = 0.59–0.75) and for the 
retrospectively estimated improvement (d = 0.92–1.00). Of note, 
after the intervention patients reported an increase in ‘average pain 
intensity during the last 12 months’, which is contradictory to the 
other estimates. One interpretation of this mismatch might be that 
some patients chose an internal anchor of a 12-month interval with 
an onset before the start of the study. This would mean that pa-
tients remember the average pain at a specific time point, namely 
one year ago rather than the average pain during the last year. 
Overall our results demonstrate that after visiting an MBSR 
course patients report improved coping abilities, better psychologi-
cal functioning, and reduced pain. These findings are in accord-
ance with meta-analyses of MBSR in general [35, 36] and effects 
found for MBSR regarding chronic pain [1]. The effect sizes re-
ported here are also compatible with or even higher than effect 
sizes of other behavioral or psychological interventions in chronic 
pain [37]. 
We did not collect systematically safety data in order to assess 
risk-benefit ratio of MBSR. In the post-intervention interviews of 
the MBSR teachers no major adverse events were reported. There 
are hardly any reports of safety issues related to MBSR, but some 
concerns regarding meditation in general [38]. 
Overall, none of the behavioral approaches for the treatment of 
chronic pain are solely satisfying as are any other treatment modali-
ties. Evidence indicates that only multimodal treatment programs 
combining different treatment options can be recommended [39, 
40]. Our results indicate that it should be considered to include also 
mindfulness-based approaches into these programs. 
With respect to the EEG data no pre-post changes could be 
found. There are slight indices that TCD variables correlate with 
pain ratings but these are very limited findings and need to be fol-
lowed up. This lack of evidence is less surprising if one considers 
that even after comparing chronic pain patients with healthy con-
trols at baseline only minimal differences could be found. From 
this first analysis [24], we concluded that TCD found in patients 
with very severe chronic pain (VAS 9–10) is not comparable to the 
population assessed in this study with an average VAS score of 5–6. 
One of the largest limitations of our pilot study is that it is not 
controlled. A control group has several functions with respect to 
the interpretations of the results. The function of a wait-list control 
is to control against natural trends. Natural trends may occur due 
to e.g. seasonal effects, or due to course of disease. Our study took 
one year and consisted of a 6-month recruitment period and a 
4-month waiting period until the start of the 2-month course. Var-
iables were compared from enrolment (t0) to the end of the inter-
vention (t2). Thus, a potential bias due to seasonal trends is quite 
unlikely. Regarding the natural course of LBP, a review reports that 
patients at baseline show relative stable LBP over time [41]. It 
therefore seems unlikely that in our case the reported improve-
ments are due to a natural improvement of the condition. The 
function of an active control group is to control for the specificity 
of the MBSR effects. Thus, our observational trial does not reveal if 
the effects occurred due to specific mindfulness elements in the 
MBSR course or due to the many unspecific aspects of the inter-
vention. From a scientific perspective which tries to nail down 
causally effective elements our results are not satisfying, and de-
mand a consecutive RCT with an active control group or a com-
parative effectiveness trial. However, we should not forget the pa-
tients’ perspective in these considerations. If there is an improve-
ment of half a SD in effect size in pain severity and quality of life 
after visiting an MBSR course, patients might be happy about that 
and less interested in the complex causal interdependence of spe-
cific and unspecific effects. Furthermore, from the current findings 
in placebo research we know that unspecific effects are also ‘real’ 
improvements which can be found in objective assessments [42, 
43] and therefore are not mere suggestive effects. From patients’ 
perspective we demonstrated that MBSR is a valid treatment op-
tion in order to improve their situation. 
Conclusion
MBSR is a feasible intervention for LBP. Patients participating 
in the course reported improved psychological functioning, im-
proved coping abilities, and a moderate reduction in pain which is 
comparable to other behavioral interventions. Based on these find-
ings, MBSR and similar mindfulness-based interventions might 
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back pain. Future research should focus on the contribution of 
mindfulness-based interventions in these programs as well as on 
RCTs assessing the specific effects of MBSR. With respect to TCD 
future research should target patients suffering from pain with 
neuropathic origin and with very severe pain ratings. 
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